References
- Green S. Ethics and the pharmaceutical industry. Australasian Pschiatry 2008; 16: 158–165.
- Mackenzie FJ, Jordens CF, Ankeny RA, McPhee J, Kerridge I. DTCA Under the radar – the need for more realistic drugs policy in Australia. Internal Medicine Journal 2007; 37: 224–228
- Doran E, Henry D. Pharmaceutical benefits scheme policy: confused and tough on patients. Internal Medicine Journal 2006; 36: 211–213
- Silagy C, May F. An Overview of Current Practices of Academic Detailing in Australia and Internationally. Canberra: Report to Commonwealth Department of Health and Family Services, 1997.
- Roughead EE, Harvey KJ, Gilbert AC. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Australian and New Zealand Journal of Medicine 1998; 28: 306–310
- Day R. Pharmaceutical company promotion. Striking a balance. Australian and New Zealand Journal of Medicine 1998; 28: 291–293
- Kerridge I, Maguire J, Newby D, et al. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations. Internal Medicine Journal 2005; 35: 206–210
- Henry DA, Kerridge IH, Hill SR, et al. Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience. Medical Journal of Australia 2005; 182: 557–560
- Henry D, Doran E, Kerridge I, Hill S, McNeill P M, Day R. Ties that bind. Multiple relationships between clinical researchers and the pharmaceutical industry. Archives of Internal Medicine 2005; 165: 2493–2496
- McNeill PM, Kerridge IH, Henry DA, et al. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Internal Medicine Journal 2006; 36: 571–578
- Doran E, Kerridge I, McNeill P, Henry D. Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry. Social Science and Medicine 2006; 62: 1510–1519
- McNeill P, Kerridge IH, Arciuili C, et al. Gifts, drug samples and other items given to medical specialists by pharmaceutical companies. Journal of Bioethical Inquiry 2006; 3: 139–148
- Foucault M. The Birth of the Clinic. Sheridan Smith AM (transl.). New York: Vintage Books, 1973.
- Illich I. Limits to Medicine. Penguin, London 1990
- Shortell SM, Waters TM, Clarke KWB, Budetti PB. Physicians as double agents. Maintaining trust in an era of multiple accountabilities. Journal of the American Medical Association 1998; 280: 1102–1108
- Smith R. Medical journals and pharmaceutical companies: uneasy bedfellows. British Medical Journal 2003; 326: 1202–1205
- Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal 2003; 326: 1167–1170
- Angell M. Is academic medicine for sale?. The New England Journal of Medicine 2000; 342: 1516–1518